Kitasato, Seiichiro <br/><br/>
Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.  [electronic resource] 

 -  Journal of biomedical materials research. Part A  03 2020 
 - 528-536 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1552-4965 
<br/><br/><label>Standard No.: </label>10.1002/jbm.a.36833  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alendronate--pharmacology<br/>Animals<br/>Bone Density Conservation Agents--pharmacology<br/>Bone Morphogenetic Protein 2--pharmacology<br/>Bone Resorption--drug therapy<br/>Calcium Phosphates--metabolism<br/>Female<br/>Humans<br/>Osteogenesis--drug effects<br/>Rabbits<br/>Recombinant Proteins--pharmacology<br/>Transforming Growth Factor beta--pharmacology